# Carie Boyd Pharmaceuticals LLC – FDA Inspection, Jul 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/095b4bfe-cd8e-4e95-8485-7617c840de0f
Source feed: FDA_Inspections

> FDA inspection 1275006 of Carie Boyd Pharmaceuticals LLC, July 18, 2025. 5 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1275006
- Company Name: Carie Boyd Pharmaceuticals LLC
- Inspection Date: 2025-07-18
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 5

## Related Documents

- [FDA Inspection 1334806 - 2026-09-08](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/cafbcd7d-0543-4bd0-bec6-2991e862ecc2)
- [FDA Inspection 1241822 - 2024-06-21](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/1a6c0434-3386-43dc-a5c3-0c0f31dd929f)
- [FDA Inspection 1172848 - 2022-06-27](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/f72e078f-a8ee-4006-883d-78234f6f2c9f)
- [FDA Inspection 1109663 - 2019-11-12](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/5952d58b-2fad-4681-8f34-e1c80067edfc)
- [FDA Inspection 1012941 - 2017-05-12](https://www.keypedia.com/records/fda_inspections/carie-boyd-pharmaceuticals-llc/ef9f4bb3-2f7f-4b21-84d0-4fef64161823)

## Related Officers

- [Investigator](https://www.keypedia.com/people/demario-l-walls/c69c4c87-f001-45ab-8d7b-b45c60226ff1)
- [Issuing Officer](https://www.keypedia.com/people/milton-j-de-jesus-tavarez/24d4ed81-7c7e-42d2-8888-1c56c25eec67)

Company: https://www.keypedia.com/companies/carie-boyd-pharmaceuticals-llc/24f4bfa5-78f1-4183-9c57-f52415673fb6

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9